Ying-ya Cao
Wuhu, 241001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fecal microbiota transplantation alleviates sepsis-induced acute lung injury by improving mitochondrial function.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: August 22, 2025
The dual effects of dexmedetomidine on intestinal barrier and intestinal motility during sepsis.
Journal: Surgery
Published: October 13, 2023
PLK1 protects intestinal barrier function during sepsis by targeting mitochondrial dynamics through TANK-NF-κB signalling.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 29, 2022
PLK1 protects intestinal barrier function in sepsis: A translational research.
Journal: Cytokine
Published: October 11, 2022
The Polo-Like Kinase 1-Mammalian Target of Rapamycin Axis Regulates Autophagy to Prevent Intestinal Barrier Dysfunction During Sepsis.
Journal: The American journal of pathology
Published: August 04, 2022
Nicotinamide mononucleotide ameliorates acute lung injury by inducing mitonuclear protein imbalance and activating the UPRmt.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: May 11, 2022
Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1-AKT signalling.
Journal: Journal of cellular and molecular medicine
Published: May 13, 2021
Sepsis induces variation of intestinal barrier function in different phase through nuclear factor kappa B signaling.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: March 29, 2021
Effect of Dexmedetomidine on Intestinal Barrier in Patients Undergoing Gastrointestinal Surgery-A Single-Center Randomized Clinical Trial.
Journal: The Journal of surgical research
Published: January 19, 2021
Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-κB signaling.
Journal: International immunopharmacology
Published: July 31, 2020
Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 12, 2018
Last Updated: 09/26/2026